Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.22.2.2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Income Statement [Abstract]        
Revenues
Operating Expenses:        
Research and development 1,139 639 3,226 2,279
Selling, general and administrative (including $463 and $577 expense from stock compensation granted to officers and directors during the three months ended June 30, 2022 and 2021, and $910 and $14,873 for the six months ended June 30, 2022 and 2021, respectively) 1,875 3,742 5,230 31,104
Loss from Operations 3,014 4,381 8,456 33,383
Other (Income) Expense        
Interest income (36) (44)
Interest expense 696
Change in fair value of derivative liability (5) 480 (23) 459
Unrealized loss on marketable securities 6 30
Total Other (Income) Expense (35) 480 (37) 1,155
Net Loss $ (2,979) $ (4,861) $ (8,419) $ (34,538)
Net loss per share - basic and diluted $ (0.10) $ (0.15) $ (0.26) $ (1.39)
Weighted average common shares outstanding - basic and diluted 31,237,560 33,516,428 31,865,425 24,925,908